Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1958 Dec;13(4):521–530. doi: 10.1111/j.1476-5381.1958.tb00247.x

The neuromuscular blocking action of benzoquinonium chloride in the cat and in the hen

W C Bowman
PMCID: PMC1481886  PMID: 13618560

Abstract

Benzoquinonium (Mytolon) has been shown to produce a curare-like rather than a decamethonium-like paralysis of neuromuscular transmission in the tibialis anterior and soleus muscle of cats and the gastrocnemius muscle of hens. In the cat, but not in the hen, benzoquinonium had an additional action in preventing both the twitch potentiating action and the anti-curare action of edrophonium, neostigmine, eserine, and tetraethyl pyrophosphate. Paralysis produced by benzoquinonium was antagonized by injected acetylcholine and by acetylcholine liberated by tetanic stimulation of the motor nerve but, in the cat, anticholinesterases were without effect even when they were first administered in circumstances in which acetylcholine accumulation might be expected to occur. These findings suggested that inhibition of cholinesterase played little part in the skeletal muscle effects of the anticholinesterases studied. Although anticholinesterases did not antagonize benzoquinonium paralysis in the cat, they nevertheless potentiated the antagonistic action of injected acetylcholine.

Full text

PDF
521

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARROWOOD J. G. Mytolon chloride: a new agent for producing muscular relaxation; preliminary report. Anesthesiology. 1951 Nov;12(6):753–761. doi: 10.1097/00000542-195111000-00012. [DOI] [PubMed] [Google Scholar]
  2. BENNETT G., TYLER C., ZAIMIS E. Mecamylamine and its mode of action. Lancet. 1957 Aug 3;273(6988):218–222. doi: 10.1016/s0140-6736(57)91598-2. [DOI] [PubMed] [Google Scholar]
  3. CUTTING W., NEWMAN H., YEE J. Effect of dosage on the rate of disappearance of ethanol from the blood of dogs. J Physiol. 1949 Dec 15;110(1-2):18–25. doi: 10.1113/jphysiol.1949.sp004417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DOUGLAS W. W., PATON W. D. The mechanisms of motor end-plate depolarization due to a cholinesterase-inhibiting drug. J Physiol. 1954 May 28;124(2):325–344. doi: 10.1113/jphysiol.1954.sp005111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DUNDEE J. W., GRAY T. C., REES G. J. Win 2747; relaxant agent; preliminary report. Anaesthesia. 1952 Jul;7(3):134–144. doi: 10.1111/j.1365-2044.1952.tb01451.x. [DOI] [PubMed] [Google Scholar]
  6. FOLDES F. F. The use of Mytolon chloride in anesthesiology. Ann N Y Acad Sci. 1951 Oct;54(3):503–511. doi: 10.1111/j.1749-6632.1951.tb39940.x. [DOI] [PubMed] [Google Scholar]
  7. GORDON J. A new relaxing agent: WIN 2747: a clinical evaluation. Anesthesiology. 1953 Jan;14(1):73–76. doi: 10.1097/00000542-195301000-00011. [DOI] [PubMed] [Google Scholar]
  8. HOBBIGER F. The mechanism of anticurare action of certain neostigmine analogues. Br J Pharmacol Chemother. 1952 Jun;7(2):223–236. doi: 10.1111/j.1476-5381.1952.tb01317.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HOPPE J. O. A pharmacological investigation of 2,5-bis-(3-diethylaminopropylamino) benzoquinone-bis-benzylchloride (WIN 2747): a new curarimimetic drug. J Pharmacol Exp Ther. 1950 Nov;100(3):333–345. [PubMed] [Google Scholar]
  10. HUNTER A. R. Win 2747: a study of a new relaxant drug. Anaesthesia. 1952 Jul;7(3):145–150. doi: 10.1111/j.1365-2044.1952.tb01452.x. [DOI] [PubMed] [Google Scholar]
  11. JEWELL P. A., ZAIMIS E. J. A differentiation between red and white muscle in the cat based on responses to neuromuscular blocking agents. J Physiol. 1954 Jun 28;124(3):417–428. doi: 10.1113/jphysiol.1954.sp005118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. PATON W. D. M., ZAIMIS E. J. The pharmacological actions of polymethylene bistrimethyl-ammonium salts. Br J Pharmacol Chemother. 1949 Dec;4(4):381–400. doi: 10.1111/j.1476-5381.1949.tb00565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. RANDALL L. O. Anticurare action of phenolic quaternary ammonium salts. J Pharmacol Exp Ther. 1950 Sep;100(1):83–93. [PubMed] [Google Scholar]
  14. RIKER W. F., Jr Exicitatory and anticurare properties of acetylcholine and related quaternary ammonium compounds at the neuromuscular junction. Pharmacol Rev. 1953 Mar;5(1):1–86. [PubMed] [Google Scholar]
  15. RIKER W. F., Jr, ROBERTS J., STANDAERT F. G., FUJIMORI H. The motor nerve terminal as the primary focus for drug-in-duced facilitation of neuromuscular transmission. J Pharmacol Exp Ther. 1957 Nov;121(3):286–312. [PubMed] [Google Scholar]
  16. RIKER W. F., Jr, WESCOE W. C., BROTHERS M. J. Studies on the interrelationship of certain cholinergic compounds; the effect of 3-acetoxy phenyltrimethylammonium methylsulfate on neuromuscular function. J Pharmacol Exp Ther. 1949 Oct;97(2):208–221. [PubMed] [Google Scholar]
  17. WESCOE W. C., RIKER W. F., Jr The pharmacology of anti-curare agents. Ann N Y Acad Sci. 1951 Oct;54(3):438–459. doi: 10.1111/j.1749-6632.1951.tb39935.x. [DOI] [PubMed] [Google Scholar]
  18. ZAIMIS E. J. Motor end-plate differences as a determining factor in the mode of action of neuromuscular blocking substances. J Physiol. 1953 Nov 28;122(2):238–251. doi: 10.1113/jphysiol.1953.sp004995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES